Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The 90% Effective Dose of Taiglididine for Inhibiting Laryngeal Mask Insertion Response in Elderly Patients

NCT07096115 is registered in ClinicalTrials.gov with The First People's Hospital of Lianyungang as lead sponsor.

NCT NCT07096115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07096115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The 90% Effective Dose of Taiglididine for Inhibiting Laryngeal Mask Insertion Response in Elderly Patients
Lead sponsor
The First People's Hospital of Lianyungang
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 1, 2025
Completion date
June 30, 2027
Enrollment
45 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

urological surgery